InvestLog
Back to Market返回行情

SCIB.ST SciBase Holding AB (publ)

STOHealthcare
$43.50+9675.28%OpenMarket Cap: $17.88B

As of 2026-06-04 09:38

Why SCIB.ST matters now

SciBase Holding AB (publ) (SCIB.ST) is a US stock in Healthcare. The latest InvestLog snapshot shows $43.50 with +9675.28% on the session and $17.88B in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -374.53, gross margin 58.6%, and operating margin -197.6%.

InvestLog's latest related AI research is a Stock Split note titled "SCIB.ST announces 1-for-100 reverse split for 2026-06-04". The latest indexable market news headline is "SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes" from GuruFocus.

Valuation

View Details

P/E (TTM)

-374.53

PEG

—

P/B

613.60

P/S

389.64

EV/EBITDA

-234.59

DCF Value

—

FCF Yield

-0.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

58.6%

Operating Margin

-197.6%

Net Margin

-207.5%

ROE

-291.7%

ROA

-91.8%

ROIC

-110.5%

Related AI Research

Stock SplitJun 4, 2026

SCIB.ST announces 1-for-100 reverse split for 2026-06-04SciBase Holding AB (publ)（SCIB.ST）宣布 1:100 合股，生效日 2026-06-04

SCIB.ST (SciBase Holding AB (publ)) completed a 1-for-100 reverse stock split on June 4, 2026, where every 100 outstanding common shares will be consolidated into one new share. This action only adjusSCIB.ST（SciBase Holding AB (publ)）于2026年6月4日正式实施1:100的反向股票拆分，每100股原有流通股份将转换为1股新增股份。该行动仅调整股份的单位计价与总股数，不会直接改变公司内在经营价值，市场参与者需关注拆分后股价档位与流动性的变化。

Latest News

SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier ChangesGuruFocus · 2026-05-18
SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier ChangesPRNewsWire · 2026-05-18
SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier ChangesPRNewsWire · 2026-05-18

Listing Info

Market

US

Exchange

STO

Currency

USD

Sector

Healthcare

Industry

Medical - Devices

Country

SE

SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.